Periorificial Dermatitis

Rosacea in Patients with Skin of Color: Not Common, But Certainly Not Rare
rosacea
by Emily Murphy, MD on
Rosacea is defined by facial erythema and telangiectasias, two features that are more difficult to appreciate in patients with skin of color. To refine our ability to diagnose rosacea in all skin types, on day two of the 2021 Skin of Color Update virtual conference, we had an informative, evidence-based lecture, “Recognizing, Diagnosing, and Treating Rosacea in Patients with Skin of Color,” by …

Continue reading "Rosacea in Patients with Skin of Color: Not Common, But Certainly Not Rare"

Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline
Periorificial Dermatitis
by NEXT STEPS IN DERM TEAM on
Broad spectrum tetracyclines are a well-known, widely used, and often successful treatment for use in inflammatory skin pathologies such as acne and rosacea. However, the steady rise of antibiotic resistance and gut dysbiosis associated with broad spectrum tetracyclines emphasizes the importance and responsibility of antibiotic stewardship. Narrow spectrum antibiotics have become increasingly impo …

Continue reading "Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline"

JDD January 2021 Issue Highlights: From COVID-19 Vaccine to Facial Rejuvenation
COVID-19 vaccine
by NEXT STEPS IN DERM TEAM on
The January issue of the Journal of Drugs in Dermatology focuses on Aesthetics Treatments, featuring an outstanding line-up of original articles from COVID-19 vaccine to facial rejuvenation. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Aesthetic Office Disaster Preparedness and Response Plan is a proactive approach for aesthetic treatment offices to manage a …

Continue reading "JDD January 2021 Issue Highlights: From COVID-19 Vaccine to Facial Rejuvenation"